Our News on Newswise

Newswise: 6192992f60641_JNCCN_Nov_Cover.jpg

New Study in JNCCN Finds Disturbing Lack of Key Leukemia Medication

New research in JNCCN—Journal of the National Comprehensive Cancer Network finds fewer than one-third of hospitals had immediate availability of a crucial medication called all-trans retinoic acid (ATRA), initiated early in the treatment of acute...
16-Nov-2021 8:35 AM EST Add to Favorites

NCCN Announces Funding for Early-Stage Non-Small Cell Lung Cancer Projects, in Collaboration with AstraZeneca

The National Comprehensive Cancer Network’s Oncology Research Program to oversee projects focused on improving patient care and outcomes in early-stage non-small cell lung cancer in collaboration with AstraZeneca.
11-Nov-2021 8:35 AM EST Add to Favorites

Newswise: 6182fdcb12f96_Alumkal.jpg

NCCN Announces Funding for Prostate Cancer Research Projects, in Collaboration with Pfizer and Astellas

The National Comprehensive Cancer Network’s Oncology Research Program to oversee projects focused on the use of enzalutamide in treating people with prostate cancer.
4-Nov-2021 8:35 AM EDT Add to Favorites

Newswise: 61708bbc2bffe_NCCNCervicalPolandCover.jpg

NCCN Works with Polish Health Leaders to Improve Cancer Standardization, Coordination, and Outcomes

International collaboration involving NCCN and Polish oncology officials publishes first of several evidence-based expert consensus guidelines with latest cancer treatment recommendations, adapted for regional needs, beginning with cervical cancer.
25-Oct-2021 7:05 AM EDT Add to Favorites

Newswise: 616d8f184c7d8_October cover-cropped.jpg

JNCCN: More People with Cancer Undergoing Radiotherapy Prefer Telemedicine to In-Person Visits

New research in JNCCN based on patient surveys before and during the COVID-19 pandemic, found higher percentage preferred telemedicine and that general patient satisfaction scores were equally high for both video conferencing and office visits.
19-Oct-2021 9:50 AM EDT Add to Favorites

Newswise: 6165f37a2152d_Cover Basal Cell 2021 DIGITAL.jpg

New Information from NCCN on Most Common Type of Cancer; Diagnosed in Millions Every Year

New NCCN Guidelines for Patients: Basal Cell Skin Cancer empowers patients and caregivers with knowledge about this widespread, preventable, and easily-cured cancer plus the rare subset that requires more aggressive treatment.
13-Oct-2021 8:45 AM EDT Add to Favorites

NCCN Meeting on Blood Cancers Empowers Interprofessional Care Teams

The NCCN Virtual Congress: Hematologic Malignancies (#NCCNhem21) will provide the latest evidence and expert consensus on emerging practices and debates in blood cancer treatment, online Thursday, October 14, 2021 – Saturday, October 16, 2021....
4-Oct-2021 8:45 AM EDT Add to Favorites

Newswise: 6153836c066ba_Small-Cell-Lung-Cancer_Cover.jpg

NCCN Publishes New Guide to Improving Knowledge and Quality of Life for Small Cell Lung Cancer Patients

NCCN announces the publication of new NCCN Guidelines for Patients®: Small Cell Lung Cancer (SCLC), which is a neuroendocrine tumor type of lung cancer that is linked to smoking and tends to be aggressive. This guide is free to view or download at...
30-Sep-2021 8:30 AM EDT Add to Favorites


See All News

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos

About

The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information and follow NCCN on Facebook @NCCNorg, Instagram @NCCNorg, and Twitter @NCCN.

Contacts

Rachel Darwin
Public Relations Manager

darwin@nccn.org

267-622-6624

Mary Ellen Martelli
Accounting Cordinator

martelli@nccn.org

267-622-6636

Erin Frantz

frantz@nccn.org

Jenn Tredwell

tredwell@nccn.org

Jessica Wilbur

wilbur@nccn.org

Twitter

close
0.26372